Article

Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface

2026-04-17

Abstract excerpt

<h4>ABSTRACT</h4> Natural killer (NK) cell-based therapies are a promising approach in cancer, but their efficacy is limited by impaired effector function and tumor-intrinsic resistance. To systematically identify therapeutic strategies that target both sides of the cancer-immune interface, we designed a multimodal immunopharmacologic screening platform comprising high-throughput co-culture drug screens, cytokine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 01e42083-a02d-5556-88ff-753db649ceb6
DOI: 10.64898/2026.04.13.717771

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interfaceDOI 10.64898/2026.04.13.717771Read

Equivocal, explicit and emergent actions of PKC isoforms in cancer.Semantic proximity Read

Surfaceome CRISPR activation screening uncovers ligands regulating tumor sensitivity to NK cell killingSemantic proximity Read

Mapping kinase-dependent tumor immune adaptation with multiplexed single-cell CRISPR screensSemantic proximity Read

Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potencySemantic proximity Read

Bridging the Gap in Immunotherapy Prediction: The AGAE Score as a Pan-Cancer Biomarker for Immune Checkpoint Inhibitor ResponseSemantic proximity Read

Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulatorsSemantic proximity Read

Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillanceSemantic proximity Read

Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillanceSemantic proximity Read

Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapySemantic proximity Read

Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activationSemantic proximity Read

DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell typesSemantic proximity Read

Perturbomics of tumor-infiltrating NK cellsSemantic proximity Read